Living the SARS-CoV-2 pandemic in Turkey.
Nat Immunol
; 22(3): 260, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33627882
Full text:
1
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Nat Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2021
Type:
Article
Affiliation country:
Turkey